BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 24733459)

  • 1. Very-high-dose caspofungin combined with voriconazole to treat central nervous system aspergillosis: substantial penetration of caspofungin into cerebrospinal fluid.
    Réminiac F; Sonneville R; Massias L; Chochillon C; Wolff M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3568-9. PubMed ID: 24733459
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term treatment of invasive sinus, tracheobroncheal, pulmonary and intracerebral aspergillosis in acute lymphoblastic leukaemia.
    Björkholm M; Kalin M; Grane P; Celsing F
    Infection; 2012 Feb; 40(1):81-5. PubMed ID: 21779887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Aspergillus pleural empyema with combined systemic and intrapleural antifungal therapy in a pediatric patient: Case report.
    Almuhareb A; Habib Z
    J Infect Public Health; 2018; 11(2):280-282. PubMed ID: 28545901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental central nervous system aspergillosis therapy: efficacy, drug levels and localization, immunohistopathology, and toxicity.
    Clemons KV; Schwartz JA; Stevens DA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4439-49. PubMed ID: 22687510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole.
    Gubler C; Wildi SM; Imhof A; Schneemann M; Müllhaupt B
    Infection; 2007 Oct; 35(5):364-6. PubMed ID: 17721739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic and toxicologic studies in a murine model of invasive pulmonary aspergillosis.
    Clemons KV; Schwartz JA; Stevens DA
    Med Mycol; 2011 Nov; 49(8):834-47. PubMed ID: 21539507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Airway Obstruction Due to Invasive Tracheobronchial Aspergillosis.
    Zheng X; Shao J; Xu J
    Am J Med Sci; 2016 Aug; 352(2):218. PubMed ID: 27524222
    [No Abstract]   [Full Text] [Related]  

  • 9. Late aspergilloma of a renal allograft without need for operative management: a case report and review of the literature.
    Shannon EM; Reid MJ; Chin-Hong P
    Transpl Infect Dis; 2016 Apr; 18(2):261-5. PubMed ID: 26751414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Need of voriconazole high dosages, with documented cerebrospinal fluid penetration, for treatment of cerebral aspergillosis in a 6-month-old leukaemic girl.
    Palmisani E; Barco S; Cangemi G; Moroni C; Dufour C; Castagnola E
    J Chemother; 2017 Feb; 29(1):42-44. PubMed ID: 25748533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infantile Aspergillus fumigatus ventriculitis successfully treated with monitoring of plasma and cerebrospinal fluid voriconazole concentration level.
    Furudate A; Hirose S; Abe K; Kawashima A; Hashimoto K; Yamazaki S; Kamei K; Ishiwada N; Hamada H; Sato M
    J Infect Chemother; 2020 Jan; 26(1):132-135. PubMed ID: 31350185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Antifungal Combination Therapy and Surgical Approach for Aspergillus fumigatus Suppurative Thyroiditis Associated with Thyrotoxicosis and Review of Published Reports.
    Nicolè S; Lanzafame M; Cazzadori A; Vincenzi M; Mangani F; Colato C; El Dalati G; Brazzarola P; Concia E
    Mycopathologia; 2017 Oct; 182(9-10):839-845. PubMed ID: 28555254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the combination of voriconazole and caspofungin in experimental pulmonary aspergillosis by different Aspergillus species.
    Zhang M; Su X; Sun WK; Chen F; Xu XY; Shi Y
    Mycopathologia; 2014 Feb; 177(1-2):11-8. PubMed ID: 24306184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole brain tissue levels in rhinocerebral aspergillosis in a successfully treated young woman.
    Elter T; Sieniawski M; Gossmann A; Wickenhauser C; Schröder U; Seifert H; Kuchta J; Burhenne J; Riedel KD; Fätkenheuer G; Cornely OA
    Int J Antimicrob Agents; 2006 Sep; 28(3):262-5. PubMed ID: 16908120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Matsuda T; Koreeda Y; Mataki H; Taira T; Noma S; Higashimoto I
    Intern Med; 2010; 49(12):1163-9. PubMed ID: 20558936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Caspofungin and voriconazole combination therapy for invasive pulmonary aspergillosis in patients with liver failure: a report of two cases].
    Zhuo J; Sun H
    Zhonghua Gan Zang Bing Za Zhi; 2014 Mar; 22(3):239-40. PubMed ID: 24919229
    [No Abstract]   [Full Text] [Related]  

  • 17. Shunt lock therapy with micafungin to treat shunt-associated Candida albicans meningitis in an infant.
    Auriti C; Piersigilli F; Ronchetti MP; Campi F; Amante PG; Falcone M; Goffredo BM
    J Antimicrob Chemother; 2016 Jul; 71(7):2060-1. PubMed ID: 27009029
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study.
    Singh N; Limaye AP; Forrest G; Safdar N; Muñoz P; Pursell K; Houston S; Rosso F; Montoya JG; Patton P; Del Busto R; Aguado JM; Fisher RA; Klintmalm GB; Miller R; Wagener MM; Lewis RE; Kontoyiannis DP; Husain S
    Transplantation; 2006 Feb; 81(3):320-6. PubMed ID: 16477215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience of the use of voriconazole, caspofungin or the combination in primary and salvage therapy of invasive aspergillosis in haematological malignancies.
    Raad II; Zakhem AE; Helou GE; Jiang Y; Kontoyiannis DP; Hachem R
    Int J Antimicrob Agents; 2015 Mar; 45(3):283-8. PubMed ID: 25455847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose optimization of voriconazole/anidulafungin combination against Aspergillus fumigatus using an in vitro pharmacokinetic/pharmacodynamic model and response surface analysis: clinical implications for azole-resistant aspergillosis.
    Siopi M; Siafakas N; Vourli S; Mouton JW; Zerva L; Meletiadis J
    J Antimicrob Chemother; 2016 Nov; 71(11):3135-3147. PubMed ID: 27494912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.